Vertex Pharmaceuticals is catching the eyes of bullish analysts, predicting a robust uptrend. Revenue trends and technical ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the Most Profitable Large Cap Stocks to Buy According to Analysts ...

The Waltham biotech signs more pharma deals than the average company, and already lists Vertex, Takeda and Biogen as its ...

In Phase III studies, Tonmya showed significantly superior analgesic effects in patients with fibromyalgia versus placebo.

B2Gold and Vertex Pharmaceuticals stand out as strong buys, driven by robust fundamentals, sector leadership, and clear ...

Vertex Pharmaceuticals reported a successful second quarter with a revenue of US$2.96 billion. This financial boost comes ...

The company's path to creating life-changing returns hinges on its ability to deliver consistent clinical and regulatory wins ...

Only one of these growth stocks is up big so far in 2025. But all three could be huge winners over the next few years.

It's the second time this year the stock has slumped significantly in one day, and it might represent another attractive ...

And one of the best ways to cash in on that is to invest in stocks that can exceed the market's performance. Two that look ...

A joint venture led by locally based REIT Diversified Healthcare Trust (NASDAQ: DHC) has received $1 billion for the refinancing of the Vertex Pharmaceuticals headquarters facility in Boston. A ...

The RMR Group secured a $1 billion refinancing for Vertex Pharmaceuticals' Boston Seaport headquarters, a five-year, interest ...